Owens & Minor (NYSE:OMI) Price Target Increased to $28.00 by Analysts at Citigroup

Owens & Minor (NYSE:OMI - Free Report) had its price objective raised by Citigroup from $24.00 to $28.00 in a research note issued to investors on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock.

A number of other research analysts have also issued reports on OMI. Barclays boosted their price target on shares of Owens & Minor from $21.00 to $23.00 and gave the stock an equal weight rating in a research note on Wednesday, February 21st. Leerink Partnrs restated a market perform rating on shares of Owens & Minor in a research note on Monday, February 26th. StockNews.com upgraded Owens & Minor from a hold rating to a buy rating in a research report on Wednesday, February 21st. TheStreet upgraded shares of Owens & Minor from a d+ rating to a c- rating in a research report on Monday, March 4th. Finally, Robert W. Baird upped their price target on shares of Owens & Minor from $24.00 to $28.00 and gave the stock a neutral rating in a research note on Wednesday, April 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of Hold and an average target price of $23.86.

Owens & Minor Stock Performance

OMI stock traded down $0.69 during trading on Tuesday, hitting $24.73. The company had a trading volume of 921,140 shares, compared to its average volume of 633,193. Owens & Minor has a 1-year low of $13.34 and a 1-year high of $28.35. The firm has a 50-day moving average price of $25.33 and a 200-day moving average price of $21.26. The company has a quick ratio of 0.52, a current ratio of 1.11 and a debt-to-equity ratio of 2.05. The firm has a market cap of $1.89 billion, a PE ratio of -45.80, a price-to-earnings-growth ratio of 0.79 and a beta of 0.43.

Owens & Minor (NYSE:OMI - Get Free Report) last released its earnings results on Tuesday, February 20th. The company reported $0.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.66 by $0.03. Owens & Minor had a positive return on equity of 11.62% and a negative net margin of 0.40%. The business had revenue of $2.66 billion for the quarter, compared to analyst estimates of $2.67 billion. During the same quarter in the previous year, the company posted $0.28 earnings per share. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. On average, analysts expect that Owens & Minor will post 1.54 earnings per share for the current year.

Insider Buying and Selling at Owens & Minor

In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $25.00, for a total transaction of $250,000.00. Following the sale, the senior vice president now owns 71,654 shares in the company, valued at approximately $1,791,350. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Owens & Minor news, SVP Michael Wayne Lowry sold 10,000 shares of the company's stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $25.00, for a total value of $250,000.00. Following the transaction, the senior vice president now directly owns 71,654 shares in the company, valued at approximately $1,791,350. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Jonathan A. Leon sold 5,000 shares of Owens & Minor stock in a transaction dated Monday, April 22nd. The stock was sold at an average price of $24.84, for a total transaction of $124,200.00. Following the sale, the senior vice president now owns 84,673 shares of the company's stock, valued at $2,103,277.32. The disclosure for this sale can be found here. 2.62% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Owens & Minor

A number of hedge funds and other institutional investors have recently made changes to their positions in OMI. Riverview Trust Co purchased a new position in Owens & Minor during the first quarter worth about $25,000. DekaBank Deutsche Girozentrale purchased a new stake in Owens & Minor in the third quarter valued at approximately $29,000. Quest Partners LLC acquired a new position in Owens & Minor during the fourth quarter worth approximately $41,000. Hexagon Capital Partners LLC raised its stake in Owens & Minor by 1,240.2% during the first quarter. Hexagon Capital Partners LLC now owns 1,568 shares of the company's stock worth $43,000 after purchasing an additional 1,451 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of Owens & Minor by 52.1% in the 1st quarter. GAMMA Investing LLC now owns 1,644 shares of the company's stock valued at $46,000 after purchasing an additional 563 shares during the last quarter. Hedge funds and other institutional investors own 98.04% of the company's stock.

Owens & Minor Company Profile

Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.